We are live on ! Find out more
Vanguard Group

Vanguard Group Portfolio holdings

AUM $6.9T
1-Year Est. Return 27.45%
 

The Vanguard Group, founded in 1975 by John C. Bogle, is one of the world's largest investment management companies, headquartered in Malvern, Pennsylvania. As of recent years, it manages trillions in assets, offering a wide range of mutual funds, ETFs, and retirement products, catering to both individual and institutional investors. Its philosophy emphasizes low fees, diversification, and a buy-and-hold strategy, making it a dominant player in the passive investing revolution.

This Fund
S&P 500
This Quarter Est. Return
+9.42%
1 Year Est. Return
+27.45%
3 Year Est. Return
+121.04%
5 Year Est. Return
+156.26%
10 Year Est. Return
+538.59%
AUM
$2.93T
AUM Growth
+$236B
Cap. Flow
+$19B
Cap. Flow %
0.65%
Top 10 Hldgs %
16.4%
Holding
4,214
New
61
Increased
2,384
Reduced
1,277
Closed
87

Top Buys

Rank Stock Value
1
BMY icon
Bristol-Myers Squibb
BMY
+$3.46B
2
TFC icon
Truist Financial
TFC
+$2.5B
3
BABA icon
Alibaba
BABA
+$2.04B
4
UBER icon
Uber
UBER
+$1.04B
5
NOW icon
ServiceNow
NOW
+$937M

Sector Composition

Rank Sector Weight
1 Technology 18.84%
2 Financials 15%
3 Healthcare 13.05%
4 Consumer Discretionary 9.93%
5 Industrials 9.65%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
PHAS
3201
DELISTED
PhaseBio Pharmaceuticals, Inc. Common Stock
PHAS
$4.53M ﹤0.01%
741,139
-2,494
-0.3% -$10.3K
OVLY icon
3202
Oak Valley Bancorp
OVLY
$280M
$4.52M ﹤0.01%
232,395
+36,467
+19% +$646K
OTIC
3203
DELISTED
Otonomy, Inc.
OTIC
$4.52M ﹤0.01%
1,179,608
OPRT icon
3204
Oportun Financial
OPRT
$370M
$4.51M ﹤0.01%
189,509
+89,509
+90% +$1.65M
FLNT
3205
Fluent
FLNT
$114M
$4.47M ﹤0.01%
297,852
-4,386
-1% -$59.2K
SBFG icon
3206
SB Financial Group
SBFG
$169M
$4.46M ﹤0.01%
237,990
HBIO icon
3207
Harvard Bioscience
HBIO
$27.9M
$4.46M ﹤0.01%
146,120
+14,460
+11% +$416K
MRKR icon
3208
Marker Therapeutics
MRKR
$18.7M
$4.46M ﹤0.01%
154,681
-581
-0.4% -$21.1K
MNTX
3209
DELISTED
Manitex International, Inc.
MNTX
$4.45M ﹤0.01%
747,545
ULBI icon
3210
Ultralife
ULBI
$88.6M
$4.42M ﹤0.01%
598,328
+87,284
+17% +$724K
GDP
3211
DELISTED
Goodrich Petroleum Corporation Common Stock
GDP
$4.39M ﹤0.01%
437,089
-1,721
-0.4% -$16.7K
ASUR icon
3212
Asure Software
ASUR
$252M
$4.34M ﹤0.01%
530,275
-41,130
-7% -$343K
TBCH
3213
Turtle Beach Corp
TBCH
$249M
$4.33M ﹤0.01%
458,480
+62,490
+16% +$613K
SOHO
3214
DELISTED
Sotherly Hotels
SOHO
$4.32M ﹤0.01%
637,212
+4,676
+0.7% +$30.8K
FBIO icon
3215
Fortress Biotech
FBIO
$92M
$4.27M ﹤0.01%
110,656
-6,491
-6% -$167K
PNRG icon
3216
PrimeEnergy Resources
PNRG
$296M
$4.26M ﹤0.01%
28,155
+10,399
+59% +$1.53M
CABA icon
3217
Cabaletta Bio
CABA
$450M
$4.25M ﹤0.01%
+303,990
New +$3.6M
YELL
3218
DELISTED
Yellow Corporation Common Stock
YELL
$4.24M ﹤0.01%
1,662,137
+79,244
+5% +$272K
IO
3219
DELISTED
ION Geophysical Corporation
IO
$4.24M ﹤0.01%
488,161
+59,449
+14% +$514K
UNB icon
3220
Union Bankshares
UNB
$109M
$4.21M ﹤0.01%
116,088
-722
-0.6% -$24.6K
AGM.A icon
3221
Federal Agricultural Mortgage Class A
AGM.A
$1.8B
$4.21M ﹤0.01%
56,505
BH icon
3222
Biglari Holdings Class B
BH
$1.22B
$4.2M ﹤0.01%
36,678
-47,891
-57% -$4.88M
GV
3223
DELISTED
Goldfield Corporation
GV
$4.17M ﹤0.01%
1,175,083
+150
+0% +$389
KA
3224
DELISTED
Kineta, Inc. Common Stock
KA
$4.17M ﹤0.01%
13,056
+4,775
+58% +$1.07M
CARM
3225
DELISTED
Carisma Therapeutics
CARM
$4.16M ﹤0.01%
200,091
+8,327
+4% +$191K

Similar funds

Vanguard Group's Q4 2019 Portfolio in Review

As of Q4 2019, Vanguard Group held 4,214 positions worth $2.93T, up 8.7% from $2.7T the previous quarter. Its ten largest holdings account for 16% of the portfolio.

Trading was light in Q4 2019: portfolio turnover was 3.5%. Vanguard Group opened 61 new positions and exited 87, leaving the 4,214-position portfolio largely intact.

By sector, the portfolio is most concentrated in Technology at 19% of assets, up from 18% a quarter earlier, followed by Financials and Healthcare.

  • Vanguard Group's largest Q4 2019 buy was Broadmark Realty Capital Inc. Common Stock: 8,851,056 shares worth $113M.
  • Vanguard Group added most to Bristol-Myers Squibb in Q4 2019, an estimated $3.46B increase.
  • Vanguard Group's biggest Q4 2019 reduction was Global Payments, cutting an estimated $641M.
  • Vanguard Group fully exited Celgene Corp in Q4 2019, selling an estimated $5.45B.
  • Vanguard Group's ten largest holdings make up 16% of its $2.93T portfolio in Q4 2019.
  • Vanguard Group opened 61 new positions and closed 87 in Q4 2019.
  • Vanguard Group's portfolio value rose 8.7% quarter-over-quarter to $2.93T.

Based on Vanguard Group's 13F filing for Q4 2019, filed 14 Feb 2020.